Articles From: Tetraphase Presents Data at ECCMID Supporting Efficacy of Two Antibiotic Candidates Against Multi-Drug Resistant Infections to Texas Added 23,390 Private Sector Jobs in April, According to ADP Regional Employment Report(SM)


2013/4/29
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that it has presented results from studies that demonstrate efficacy of two next-generation antibiotic candidates against community-acquired multi-drug resistant (MDR) infections.
Sign-up for Tetraphase Presents Data at ECCMID Supporting Efficacy of Two Antibiotic Candidates Against Multi-Drug Resistant Infections investment picks
2013/5/13
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the first quarter ended March 31, 2013.
Sign-up for Tetraphase Reports First Quarter 2013 Financial Results investment picks
2013/5/8
Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder NORTH WALES, Pa.
Sign-up for Teva and Alexza Announce Teva's License to Market ADASUVE® in the U.S. investment picks
2013/5/8
Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) , and Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) announced today that the companies have entered into an exclusive U.S. license and supply agreement for ADASUVE (loxapine) inhalation powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.
Sign-up for Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S. investment picks
2013/4/23
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402 investment picks
2013/2/14
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Announces FDA Approval of Generic Adderall XR® investment picks
2013/2/5
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Announces First Patient Enrolled in Largest Clinical Study to Date Evaluating AZILECT® for Mild Cognitive Impairment in Parkinson's Disease investment picks
2013/1/31
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Announces Termination of Agreements with CureTech investment picks
2013/3/1
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Calls 5.550% Senior Notes Due 2016 for Redemption investment picks
2013/4/24
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Creates Specialty-Medicines Division, Names Koremans Unit's CEO investment picks
2013/4/24
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Establishes Global Specialty Medicines Group investment picks
2013/4/29
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer investment picks
2013/3/8
In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Files 2012 Annual Report on Form 20-F investment picks
2013/4/23
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Gets Orphan Drug Designation for XEN402 investment picks
2013/3/27
GOLETA, Calif.
Sign-up for Teva Invigorates Timeless Sandal Silhouettes with Limited-Edition Offering investment picks
2013/3/4
Leading Outdoor Brand launches biggest campaign to date behind new TevaSphere innovation GOLETA, Calif.
Sign-up for Teva Launches Global Marketing Campaign "Unfollow" investment picks
2013/4/8
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan investment picks
2013/5/8
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Pharmaceutical, Alexza Pharmaceuticals Reach Licensing Pact for Adasuve investment picks
2013/2/11
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Pharmaceuticals Announces Appointment of Dr. Arie Belldegrun to Board of Directors investment picks
2013/5/2
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Reports First Quarter 2013 Results investment picks
2013/3/12
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Present at the 2013 Barclays Global Healthcare Conference investment picks
2013/2/25
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference investment picks
2013/5/14
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference investment picks
2013/3/14
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Present New Research on CNS Product Portfolio and Pipeline at 2013 American Academy of Neurology Annual Meeting investment picks
2013/4/9
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Report First Quarter 2013 Financial Results on May 2, 2013 investment picks
2013/5/6
Teva Women’s Health, a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Women’s Health to Present New Data at the 61st Annual Meeting of the American Congress of Obstetricians and Gynecologists investment picks
2013/4/8
Teva-Handok today announced the appointment of Yoo Suk Hong as the first Chief Executive Officer of the business venture established between Teva Pharmaceutical Industries Ltd.
Sign-up for Teva-Handok Names Yoo Suk Hong as Chief Executive Officer investment picks
2013/3/26
Team will develop and manufacture GSK's next generation influenza vaccines to protect the nation against global pandemics AUSTIN, Texas and PHILADELPHIA , March 26, 2013 /PRNewswire/ -- GlaxoSmithKline plc (GSK) and The Texas A&M University System announced today that the U.S. Department of Health and Human Services (DHHS) has approved the establishment of a $91 million influenza-vaccines manufacturing facility as the anchor of the Center for Innovation in Advanced Development and Manufacturing (CIADM) in Bryan-College Station, Texas .
Sign-up for Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility in Texas investment picks
2013/5/10
http://media.marketwire.com/attachments/201304/60427_ADPlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1016006&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for Texas Added 23,390 Private Sector Jobs in April, According to ADP Regional Employment Report(SM) investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Tetraphase Presents Data at ECCMID Supporting Efficacy of Two Antibiotic Candidates Against Multi-Drug Resistant Infections to Texas Added 23,390 Private Sector Jobs in April, According to ADP Regional Employment Report(SM)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity